Considering the complexity of the mTOR signaling pathway, further studies focusing on the different members of the mTOR complex and other proteins involved in the pathway are needed to identify specific targets of amiodarone in bladder cancer. The gene discussed is MTOR; the disease is urinary bladder carcinoma.